Almirall announces resignation of Gianfranco Nazzi as CEO, position assumed by Carlos Gallardo on interim basis
Almirall comunica la renuncia de Gianfranco Nazzi como CEO, cargo que asume Carlos Gallardo de forma provisional
Intel ID : 353357
|
||||
| Intel ID | 353357 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Almirall
(31 Dec 2022) |
Revenue: EUR 895,52m EBITDA: EUR 187,28m Net Debt: EUR 5.791,57m People: 1846 |
|
| Date |
|
|
| Country | ![]() |
|
| Geography | ![]() |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | ![]() |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.
